Drug Money! North American Life Science Sector Wraps Up $16 Billion in Project Investments in 2017
Drug Money! North American Life Science Sector Wraps Up $16 Billion in Project Investments in 2017
Attachment: pharma complete
SUGAR LAND--February 2, 2018--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--There is big money to be made, and spent, when it comes to the life science industry. Even before citizens reap the hoped-for alleviation or cure of a medical condition courtesy of its products, the North American life science industry delivered $16 billion into completing 1,241 projects in 2017. The healthy injections of cash that the industry pours into local economies, both during the construction of and long after completion, is what makes these industry projects so attractive to every region.
Within this article: North American Pharmaceutical & Biotech project completions in 2017.
Additional companies: Jacobs Engineering Group Incorporated (NYSE:JEC)
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Nothing to Sneeze At! Global Pharma-Bio Sector Wraps Up $4.74 Billion in Co...
- It's a Wrap: Pharmaceutical-Biotech-Life Science Sector Completes $5.5 Bill...
- U.S. Army Continues Construction on Massive, $800 Million Medical Research ...
- BHP Updates Progress on Major Canadian Potash-Mining Project
- U.S. Lithium Sector Primed for Growth